Showing results (1401-1410 of 1,430) with videos related to
Sort By:
Pageof 143
Oncotarget|April 23, 2016
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched studyShan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.Drug Development Research|August 3, 2023
Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving uPA/uPAR signalingChang-Zhi Li, Yuan-Yuan Qiang, Zhi-Jie Liu, et al.Cancer Communications (London, England)|September 27, 2018
Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignanciesChaofeng Li, Bingzhong Jing, Liangru Ke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trialCheng Xu, Si-Yang Wang, Man Nie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial stagingLin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trialSu-Mei Cao, Qi Yang, Ling Guo, et al.The Lancet. Oncology|April 15, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trialXing Lv, Xun Cao, Wei-Xiong Xia, et al.European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.Nature Communications|March 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trialLi-Ting Liu, Xue-Song Sun, Ting-Ting Quan, et al.Pageof 143